Discount Agreements for Dolutegravir and Rilpivirin
AOK Rheinland-Pfalz/Saarland is offering open discount agreements for the active ingredients Dolutegravir and Rilpivirin to pharmaceutical companies. The agreements have a maximum term of 24 months, starting no earlier than August 1, 2026.
CONTRACTING AUTHORITY
Name
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
City
Eisenberg
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
not-allowed
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
712 days remaining(LOT-0001)
Published